Search research articles
Contact Us
Filters
Showing results (321-330 of 349) with videos related to
Page
of 35
Sort By:
Blood
|
April 13, 2019
PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomas
Marién Pascual, María Mena-Varas, Eloy Francisco Robles, et al.
Blood
|
July 7, 2021
The alternative RelB NF-κB subunit is a novel critical player in diffuse large B-cell lymphoma
Baptiste Eluard, Stéphanie Nuan-Aliman, Nathalie Faumont, et al.
Blood
|
June 3, 2011
miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy
Santiago Montes-Moreno, Nerea Martinez, Beatriz Sanchez-Espiridión, et al.
Blood
|
May 13, 2025
A Multi-Omics Approach Reveals Novel Regulators of Plasma Factor V Levels: highlight on CLEC4M as a Clearance Receptor
Gaëlle Munsch, Adarsh Mohapatra, Astrid van Hylckama Vlieg, et al.
Human Molecular Genetics
|
January 6, 2017
Genome-wide association study with additional genetic and post-transcriptional analyses reveals novel regulators of plasma factor XI levels
Bengt Sennblad, Saonli Basu, Johanna Mazur, et al.
Nature Communications
|
May 27, 2017
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies
Edurne San José-Enériz, Xabier Agirre, Obdulia Rabal, et al.
Communications Biology
|
November 20, 2025
Characterization of the bone marrow architecture of multiple myeloma using spatial transcriptomics
Emma Muiños-Lopez, Ana Rosa Lopez-Perez, Laura Sudupe, et al.
Science (New York, N.Y.)
|
September 11, 2020
Cell type-specific genetic regulation of gene expression across human tissues
Sarah Kim-Hellmuth, François Aguet, Meritxell Oliva, et al.
Blood Cancer Discovery
|
March 5, 2024
Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma
Irene M Ghobrial, Nicole Gormley, Shaji K Kumar, et al.
Science Advances
|
January 19, 2022
Preneoplastic somatic mutations including <i>MYD88</i><sup>L265P</sup> in lymphoplasmacytic lymphoma
Sara Rodriguez, Jon Celay, Ibai Goicoechea, et al.
Page
of 35
Search research articles
Search
Showing results (321-330 of 349) with videos related to
Sort By:
Page
of 35
Blood
|
April 13, 2019
PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomas
Marién Pascual, María Mena-Varas, Eloy Francisco Robles, et al.
Blood
|
July 7, 2021
The alternative RelB NF-κB subunit is a novel critical player in diffuse large B-cell lymphoma
Baptiste Eluard, Stéphanie Nuan-Aliman, Nathalie Faumont, et al.
Blood
|
June 3, 2011
miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy
Santiago Montes-Moreno, Nerea Martinez, Beatriz Sanchez-Espiridión, et al.
Blood
|
May 13, 2025
A Multi-Omics Approach Reveals Novel Regulators of Plasma Factor V Levels: highlight on CLEC4M as a Clearance Receptor
Gaëlle Munsch, Adarsh Mohapatra, Astrid van Hylckama Vlieg, et al.
Human Molecular Genetics
|
January 6, 2017
Genome-wide association study with additional genetic and post-transcriptional analyses reveals novel regulators of plasma factor XI levels
Bengt Sennblad, Saonli Basu, Johanna Mazur, et al.
Nature Communications
|
May 27, 2017
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies
Edurne San José-Enériz, Xabier Agirre, Obdulia Rabal, et al.
Communications Biology
|
November 20, 2025
Characterization of the bone marrow architecture of multiple myeloma using spatial transcriptomics
Emma Muiños-Lopez, Ana Rosa Lopez-Perez, Laura Sudupe, et al.
Science (New York, N.Y.)
|
September 11, 2020
Cell type-specific genetic regulation of gene expression across human tissues
Sarah Kim-Hellmuth, François Aguet, Meritxell Oliva, et al.
Blood Cancer Discovery
|
March 5, 2024
Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma
Irene M Ghobrial, Nicole Gormley, Shaji K Kumar, et al.
Science Advances
|
January 19, 2022
Preneoplastic somatic mutations including <i>MYD88</i><sup>L265P</sup> in lymphoplasmacytic lymphoma
Sara Rodriguez, Jon Celay, Ibai Goicoechea, et al.
Page
of 35